A recent report by the World Health Organization (WHO) indicates that every region of the world is headed rapidly toward a “post-antibiotic era,” in which even common infections and minor injuries can kill.
Read More
Molecular diagnostics company Diagnovus and Cincinnati Children’s Hospital Medical Center are partnering to commercialize the first genomic assay to help physicians diagnose and treat eosinophilic esophagitis, a debilitating inflammatory condition.
Read More
Vermillion, a diagnostics company focused on gynecologic cancers and women’s health, has launched Aspira Labs, which will specialize in applying biomarker-based technologies for the management of gynecologic cancers.
Read MorePrior to passage of the Protecting Access to Medicare Act of 2014, covered entities throughout the United States were working furiously to meet the October 1, 2014, deadline for implementation of the latest edition of the...
Read More
Laboratory testing for hematological disorders ranges from highly automated routine laboratory tests to cutting-edge technologies. This post is a sidebar to our May 2014 feature on Hematology Testing.
Read More